Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
386.3 USD | +0.17% | -1.08% | +26.04% |
May. 29 | Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing | MT |
May. 29 | TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target | MT |
Financials (USD)
Sales 2024 * | 2.17B | Sales 2025 * | 2.52B | Capitalization | 11.94B |
---|---|---|---|---|---|
Net income 2024 * | 360M | Net income 2025 * | 421M | EV / Sales 2024 * | 5.17 x |
Net cash position 2024 * | 715M | Net cash position 2025 * | 1.05B | EV / Sales 2025 * | 4.32 x |
P/E ratio 2024 * |
34.4
x | P/E ratio 2025 * |
29.5
x | Employees | 5,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.11% |
Latest transcript on Medpace Holdings, Inc.
1 day | +0.17% | ||
1 week | -1.08% | ||
1 month | -2.90% | ||
3 months | -4.43% | ||
6 months | +40.28% | ||
Current year | +26.04% |
Managers | Title | Age | Since |
---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 49 | 18-10-31 |
Jesse Geiger
PSD | President | 49 | 07-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Davenport
BRD | Director/Board Member | 72 | 18-08-12 |
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Director/Board Member | 64 | 18-08-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 2 M€ | -.--% | ||
0.49% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 386.3 | +0.17% | 292,758 |
24-05-30 | 385.7 | -0.59% | 146,146 |
24-05-29 | 388 | -0.72% | 240,223 |
24-05-28 | 390.8 | +0.07% | 170,029 |
24-05-24 | 390.6 | -0.01% | 112,402 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.04% | 11.94B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- MEDP Stock